| TRADING CENTER |
| 12 Companies With Ironclad Balance Sheets - MotleyFool.com | |
| Top Takes From RealMoney - at TheStreet.com | |
| MDVN Starts New Alzheimer's Trials - Analyst Blog - Zacks.com | |
| 4-Star Stocks Poised to Pop: Alkermes - MotleyFool.com | |
| The Hottest Sector for 2010 - MotleyFool.com | |
| Grandma knows best when it comes to drugs - FT.com | |
| AstraZeneca Beats, Raises - Analyst Blog - Zacks.com | |
| Forest reports positive trials of constipation drug - Reuters | |
| Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Tr... - Business Wire | |
| Amgen, Amerisource sued over drug kickback scheme - Reuters | |
| Forest Laboratories, Inc. and Gedeon Richter Announce Positive Results from a Phase I... - Business Wire | |
| Trading Review for Discovery Laboratories Inc. Issued by Beacon Equity - GlobeNewswire | |
Mixed results for big pharma - CNNMoney.com |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 63.30 | 0.00 / 0.00% | 13.82 |
| PFE | Pfizer Inc | 18.59 | 0.00 / 0.00% | 15.62 |
| NVS | Novartis AG | 55.85 | 0.00 / 0.00% | 15.69 |
| 2009 Revenue: | $3.8 B | Headquarters: New York, NY |
| Employees: | 5,225 | CEO: Howard Solomon |
| Net Income: | $767.7 M | Industry: Pharmaceuticals |
| Market Cap: | $8.9 B | Website: www.frx.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| FRX | 31.10 | 0.00 / 0.00% | 31.10 | 0.00 | 0.00 | Profile Chart News |